Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Letter to the Editor
2009:75:6;613-614
doi: 10.4103/0378-6323.57729
PMID: 19915248

Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids

Arpana Rijal, S Agrawal
 Department of Dermatology, B. P. Koirala Institute of Health Science, Dharan, Nepal

Correspondence Address:
Arpana Rijal
Department of Dermatology and Venereology, B.P. Koirala Institute of Health Sciences, Dharan
Nepal
How to cite this article:
Rijal A, Agrawal S. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids. Indian J Dermatol Venereol Leprol 2009;75:613-614
Copyright: (C)2009 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are drug-induced or idiopathic reaction patterns characterized by skin tenderness, along with erythema of the skin, followed by extensive cutaneous and mucosal sloughing. They are life-threatening due to multisystem involvement and mortality ranges from 25 - 70%. [1] SJS includes cases with less than 10% epidermal detachment, mucosal lesions, and widespread purpuric lesions; SJS / TEN overlap when the epidermal detachment is between 10 and 30%; mucosal lesions, widespread purpuric lesions, and TEN when the epidermal detachment is more than 30%, and mucosal lesions and widespread purpuric lesions are present. [2] Early intervention with corticosteroids controls inflammation, [2] as corticosteroids are potent agents that target several intracellular processes, to modify almost all components of inflammatory and immune responses, hence, some favor early use of corticosteroids. Some studies suggest that systemic steroids adversely affect the outcome by increasing the risk of septicemia and gastrointestinal bleeding. [3],[4],[5],[6]

A retrospective analysis of the records of patient′s admitted in the dermatology ward with SJS,SJS-TEN overlap, and TEN, between 1997 and 2005, was performed. A detailed study of case records regarding clinical presentation, investigations, treatments, treatment outcome, and provoking factor was done.

The total number of patients admitted with SJS was 10 (41.6%), with SJS-TEN overlap was eight (33.3), and with TEN was six (23%). Mean age of the patients was 26.4 years. The mean percentage of body surface area involved was 35.5%. The patients reported to the hospital within 1.9 days of appearance of the lesions. Prodromal signs were seen in all the patients.

The drugs implicated in the decreasing order of frequency were phenytoin 8 (33.3%) carbamazapine 5 (20.6%), sulfonamides 5 (20.6%), amoxicillin 3 (12.5%), ibuprofen 2 (8.33%), and ciprofloxacin 1 (4.16%). Viral infection was seen in one case [Table - 1].

The offending drug was stopped immediately. The patients were bathed daily and paraffin gauze was applied over the raw body surface area. Antibiotics, ceftriaxone, and gentamycin were given prophylactically. Twenty-two patients were started on oral or intravenous (IV) corticosteroids with doses ranging from 1 to 3 mg / kg / body weight. Oral pednisolone was given in patients who could take it orally. Dexamethasone was given IV. Corticosteroids were tapered according to the response seen. The patients, received corticosteroids for 14 - 30 days (mean 15 days). Two patients did not receive corticosteroids as one had sepsis and in the other the etiology was of viral origin, the patient had chicken pox. A Tzanck smear was done, which showed multiple multinucleated giant cells, and serum IgM was raised above normal. Strict monitoring of the patients′ vitals was done daily. Sepsis screening was done at baseline and twice weekly. All the patients recovered. The average period of stay in hospital was 19.4 days (range 7 - 41 days). All patients were kept in isolation . The principle of symptomatic treatment are the same as that for burns and include fluid replacement, nutritional support, and antimicrobial therapy. [3] Early reporting by our patients, within 1.9 days of appearance of lesions, and the early use of corticosteroids may have favored a better prognosis. Patterson [7] reported the effectiveness of early steroid administration in the Stevens-Johnson syndrome in 41 cases.

Lesser total body surface area involvement showed a better survival rate as seen in other studies. [8] Most of our patients, 75% (18 cases), had 30% or less than 30% of body surface area involvement. Younger patients had better prognosis as seen from other studies. [9],[10],[11] The majority of our patients were between 18 and 30 years. From our analysis we have seen that steroids, when given early, preferably within 72 hours, in younger patients, with lesser body surface area involvement, without any comorbidity, and under very strict supervision, preferably in well-equipped centers, prove beneficial to the patients with SJS / TEN.

References
1.
Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. Management of Stevens - Johnson syndrome and TEN. J Pediatr 1989;115:881-7.
[Google Scholar]
2.
Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005;153:241-53.
[Google Scholar]
3.
Heimbach DM, Engrav LH, Marvin JA, Harnar TJ, Grube BJ. Toxic epidermal necrolysis: a step forward in treatment: JAMA 1987;257:2171-5.
[Google Scholar]
4.
Rzany B, Schmitt H, Schöpf E. Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol 1991;71:171-2.
[Google Scholar]
5.
Hansbrough JF, Muller P, Noordenbos J, Dore C. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2001;22:97-8.
[Google Scholar]
6.
Smoot EC 3rd. Treatment issues in the care of patients with toxic epidermal necrolysis: Burns 1999;25:439-42.
[Google Scholar]
7.
Patterson R, Miller M, Kaplan M, Doan T, Brown J, Detjen P, et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy 1994;73:27-34.
[Google Scholar]
8.
Engelhardt SL, Schurr MJ, Helgerson RB. Toxic Epidermal Necrolysis: an analysis of referral pattern and steroid usage. J Burn Care Rehabil 1997;18:520-4.
[Google Scholar]
9.
Criton S, Devi K, Sridevi PK, Asokan PU. Toxic Epidermal necrolysis - a retrospective study. Int J Dermatol 1997;36:923-5.
[Google Scholar]
10.
Tripathi A, Ditto AM, Grammer LC, Greenberger PA, McGrath KG, Zeiss CR, et al. Corticosteroid therapy in an additional 13 cases of Stevens - Johnson syndrome: a total series of 67 cases. Allergy Asthma Proc 2000;21:101-5.
[Google Scholar]
11.
Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG. A ten year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2000;21:199-204.
[Google Scholar]

Fulltext Views
108

PDF downloads
33
Show Sections